Predicting mortality for paediatric inpatients where malaria is uncommon

Dana C Clifton1, Habib O Ramadhani, Levina J Msuya

  • 1Division of Infectious Diseases and International Health, Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA.

Insights

In low malaria transmission areas, Integrated Management of Childhood Illness (IMCI) criteria effectively predict non-malarial severe illness deaths in children. Clinical examination is crucial for prognosis, as laboratory results were less predictive.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Global Health

Background:

  • Sub-Saharan Africa is experiencing an increase in children residing in low malaria transmission zones.
  • Accurate identification of non-malarial severe illness is critical for improving pediatric outcomes in these regions.

Purpose of the Study:

  • To evaluate the effectiveness of Integrated Management of Childhood Illness (IMCI) criteria in predicting inpatient mortality among children with severe non-malarial febrile illness.
  • To assess the utility of clinical signs versus laboratory results in determining prognosis for severe pediatric illness in a low malaria transmission setting.

Main Methods:

  • A prospective cohort study was conducted with febrile pediatric inpatients at a tertiary referral center in northern Tanzania.
  • Data were collected using IMCI criteria, and diagnostic specimens were obtained.
  • Statistical analysis identified factors associated with inpatient death.

Main Results:

  • Out of 466 participants, 7.3% died. Malaria was diagnosed in only 2.4% of cases.
  • Clinical signs such as prolonged capillary refill time, inability to drink, lethargy, and respiratory difficulty were significantly associated with inpatient death.
  • Severe wasting and a low Blantyre Coma Scale (BCS) score were independent predictors of mortality.

Conclusions:

  • IMCI criteria demonstrated good performance in predicting inpatient death from non-malarial causes in a low malaria transmission area.
  • Clinical examination proved more valuable than laboratory results for assessing prognosis.
  • Healthcare providers should consider local malaria prevalence to avoid over-diagnosis and ensure timely treatment for non-malarial severe illnesses.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...